Company Filing History:
Years Active: 2018
Title: Annette Koerner: Innovator in Hematological Treatments
Introduction
Annette Koerner is a notable inventor based in Grenzach-Wyhlen, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of hematological disorders. Her innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Annette Koerner holds a patent for GlyT1 inhibitors for use in the treatment of hematological disorders. This invention focuses on compounds that serve as GlyT1 inhibitors, specifically targeting conditions such as sickle cell disease and thalassemia. Additionally, her work addresses the treatment of patients suffering from iron overload syndromes, including hereditary hemochromatosis.
Career Highlights
Throughout her career, Annette has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her expertise and contribute to groundbreaking research in her field.
Collaborations
Annette Koerner has collaborated with esteemed colleagues, including Daniela Alberati and Emmanuel Pinard. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Annette Koerner's contributions to the field of hematological treatments through her innovative patents highlight her role as a leading inventor. Her work continues to impact the lives of patients dealing with serious health conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.